Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Patrick Neven | Researchclopedia

Back to researchers

Patrick Neven

Universitair Ziekenhuis Leuven ORCID

1,178

Works

38,597

Citations

88

h-index

385

i10-index

Research Topics

Breast Cancer Treatment Studies Advanced Breast Cancer Therapies Estrogen and related hormone effects

Affiliations

AstraZeneca (United Kingdom)2011–2011

Broad Institute2014–2014

Twitter (United States)2024–2024

Goethe University Frankfurt2012–2012

Gynecologic Oncology Group2023–2023

Top Works

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

George W. Sledge,Masakazu Toi,et al.

20171,623 citations

HER2/EGFR in Cancer Research

Cancer Treatment and Pharmacology

Endometrial cancer

Frédéric Amant,Philippe Moerman,et al.

20051,506 citations

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3

Dennis J. Slamon,Patrick Neven,et al.

20181,087 citations

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2

George W. Sledge,Masakazu Toi,et al.

2019964 citations

A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer

Ayse Bassez,Hanne Vos,et al.

2021868 citations

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

Dennis J. Slamon,Patrick Neven,et al.

2019822 citations

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

Xiaohong R. Yang,Jenny Chang‐Claude,et al.

2010714 citations

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

François‐Clément Bidard,Virginia Kaklamani,et al.

2022646 citations

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

BOCS,Kyriaki Michailidou,et al.

2015630 citations